These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11557866)

  • 21. To B or not to B: TNF family signaling in lymphocytes.
    Siegel RM; Lenardo MJ
    Nat Immunol; 2001 Jul; 2(7):577-8. PubMed ID: 11429537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF.
    Tardivel A; Tinel A; Lens S; Steiner QG; Sauberli E; Wilson A; Mackay F; Rolink AG; Beermann F; Tschopp J; Schneider P
    Eur J Immunol; 2004 Feb; 34(2):509-18. PubMed ID: 14768056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
    Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
    Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of APRIL and BAFF in lymphocyte activation.
    Schneider P
    Curr Opin Immunol; 2005 Jun; 17(3):282-9. PubMed ID: 15886118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival signaling in resting B cells.
    Patke A; Mecklenbräuker I; Tarakhovsky A
    Curr Opin Immunol; 2004 Apr; 16(2):251-5. PubMed ID: 15023421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.
    Mackay F; Schneider P
    Cytokine Growth Factor Rev; 2008; 19(3-4):263-76. PubMed ID: 18514565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen.
    Schneider P; Takatsuka H; Wilson A; Mackay F; Tardivel A; Lens S; Cachero TG; Finke D; Beermann F; Tschopp J
    J Exp Med; 2001 Dec; 194(11):1691-7. PubMed ID: 11733583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis.
    Zhang M; Ko KH; Lam QL; Lo CK; Srivastava G; Zheng B; Lau YL; Lu L
    Int Immunol; 2005 Aug; 17(8):1081-92. PubMed ID: 16000326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular basis of common variable immunodeficiency.
    Castigli E; Geha RS
    J Allergy Clin Immunol; 2006 Apr; 117(4):740-6; quiz 747. PubMed ID: 16630927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunology. Lymphocyte survival--ignorance is BLys.
    Laâbi Y; Strasser A
    Science; 2000 Aug; 289(5481):883-4. PubMed ID: 10960320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BAFF, APRIL and human B cell disorders.
    Tangye SG; Bryant VL; Cuss AK; Good KL
    Semin Immunol; 2006 Oct; 18(5):305-17. PubMed ID: 16916610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses.
    Ye Q; Wang L; Wells AD; Tao R; Han R; Davidson A; Scott ML; Hancock WW
    Eur J Immunol; 2004 Oct; 34(10):2750-9. PubMed ID: 15368291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decoy receptors thwart B cells.
    Ware CF
    Nature; 2000 Apr; 404(6781):949-50. PubMed ID: 10801112
    [No Abstract]   [Full Text] [Related]  

  • 34. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator.
    Baker KP; Edwards BM; Main SH; Choi GH; Wager RE; Halpern WG; Lappin PB; Riccobene T; Abramian D; Sekut L; Sturm B; Poortman C; Minter RR; Dobson CL; Williams E; Carmen S; Smith R; Roschke V; Hilbert DM; Vaughan TJ; Albert VR
    Arthritis Rheum; 2003 Nov; 48(11):3253-65. PubMed ID: 14613291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor.
    Deshayes F; Laprée G; Portier A; Richard Y; Pencalet P; Mahieu-Caputo D; Horellou P; Tsapis A
    Oncogene; 2004 Apr; 23(17):3005-12. PubMed ID: 14691452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BAFF: a fundamental survival factor for B cells.
    Mackay F; Browning JL
    Nat Rev Immunol; 2002 Jul; 2(7):465-75. PubMed ID: 12094221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BLyS and B cell homeostasis.
    Woodland RT; Schmidt MR; Thompson CB
    Semin Immunol; 2006 Oct; 18(5):318-26. PubMed ID: 16931037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity.
    Yu G; Boone T; Delaney J; Hawkins N; Kelley M; Ramakrishnan M; McCabe S; Qiu WR; Kornuc M; Xia XZ; Guo J; Stolina M; Boyle WJ; Sarosi I; Hsu H; Senaldi G; Theill LE
    Nat Immunol; 2000 Sep; 1(3):252-6. PubMed ID: 10973284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site.
    Gordon NC; Pan B; Hymowitz SG; Yin J; Kelley RF; Cochran AG; Yan M; Dixit VM; Fairbrother WJ; Starovasnik MA
    Biochemistry; 2003 May; 42(20):5977-83. PubMed ID: 12755599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TACI and BAFF-R mediate isotype switching in B cells.
    Castigli E; Wilson SA; Scott S; Dedeoglu F; Xu S; Lam KP; Bram RJ; Jabara H; Geha RS
    J Exp Med; 2005 Jan; 201(1):35-9. PubMed ID: 15630136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.